Kymera Therapeutics, Inc.
METHODS OF TREATING MUTANT LYMPHOMAS
Last updated:
Abstract:
The present invention relates to methods of treating MYD88-mutant B-cell lymphomas using IRAK4 degraders.
Status:
Application
Type:
Utility
Filling date:
29 Jul 2021
Issue date:
24 Feb 2022